Twist Bioscience Corporation (TWST)
NASDAQ: TWST · IEX Real-Time Price · USD
58.08
+0.57 (0.99%)
At close: Jul 26, 2024, 4:00 PM
60.90
+2.82 (4.86%)
After-hours: Jul 26, 2024, 4:41 PM EDT

Twist Bioscience Revenue

Twist Bioscience had revenue of $75.30M in the quarter ending March 31, 2024, with 25.13% growth. This brings the company's revenue in the last twelve months to $277.49M, up 21.79% year-over-year. In the fiscal year ending September 30, 2023, Twist Bioscience had annual revenue of $245.11M with 20.41% growth.

Revenue (ttm)
$277.49M
Revenue Growth
+21.79%
P/S Ratio
12.13
Revenue / Employee
$301,943
Employees
919
Market Cap
3.38B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 2023245.11M41.54M20.41%
Sep 30, 2022203.57M71.23M53.83%
Sep 30, 2021132.33M42.23M46.87%
Sep 30, 202090.10M35.72M65.67%
Sep 30, 201954.39M28.96M113.89%
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Oscar Health 6.54B
Amedisys 2.25B
HUTCHMED (China) 838.00M
GoodRx Holdings 764.16M
Azenta 651.76M
Inari Medical 520.66M
Denali Therapeutics 295.39M
ADMA Biologics 283.18M
Revenue Rankings